The Cumming Global Centre for Pandemic Therapeutics

The Cumming Global Centre for Pandemic Therapeutics (CGCPT) at the University of Melbourne is seeking to appoint Pre-eminent (Professor) Researchers across six strategic areas as part of a major faculty recruitment initiative. Based within the world-leading Peter Doherty Institute for Infection and Immunity, the CGCPT leads a bold, globally connected mission to accelerate the development of next-generation, rapid-response therapeutic platforms for pathogens of pandemic potential.

We invite applications from internationally recognised researchers in the following fields:

Bioinformatics, Artificial Intelligence and Computational Biology
Structural Biology and Small Molecule Drug Development
Pathogens of Pandemic Potential: Virology and Bacteriology
Immunology and Immunotherapies, including Antibodies and Nanobodies
Nucleic Acid Targeting and mRNA Technology
Model Systems: Organoids and Animal Models for Therapeutic Development

These positions offer a once-in-a-generation opportunity to lead transformative research, shape global collaborations, and deliver real-world impact within a mission-driven, fully funded research environment.

Please ensure you include the reference number for the specific role you are applying for. Reference numbers are listed in the ‘How to Apply’ section below.

About The Cuming Global Centre for Pandemic Therapeutics

The Cumming Global Centre for Pandemic Therapeutics (Centre) was established in September 2022 within the Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and Royal Melbourne Hospital.

With an ambitious 20-year mission to advance the science behind therapeutic development for pathogens of pandemic potential, the Centre will bring together leading scientists from around the globe to develop novel platform technologies using a ‘plug and play’ approach. This means that treatment solutions can be rapidly adapted to new pathogens within much shorter timeframes than currently possible after a new virus is identified, transforming future pandemic management and saving lives.

The Centre was made possible by a $250 million donation from Mr Geoffrey Cumming – the largest philanthropic donation to medical research in Australia’s history. The Victorian Government also signed on as a Major Supporting Partner, committing $75 million in funding.

Useful links

Our Mission

The mission of the Cumming Global Centre for Pandemic Therapeutics is to develop new platform technologies, which will enable the rapid design and development of therapeutics at speed for pathogens of pandemic potential.

When submitting your application, please ensure you include the reference number for the role you are applying for:
- Immunology and Immunotherapies – Ref #A040699
- Model Systems (Organoids) – Ref #A040701
- Nucleic Acid Targeting and mRNA – Ref #A040700
- Pathogens of Pandemic Potential – Ref #A040698
- Structural Biology – Ref #A040697
- AI Computational Biology - Ref#A040880
Application deadline: 4 July 2025
Please send us your application as soon as possible, as we are continuously assessing candidates for these assignments.
All applications must include the following information so the panel can assess your suitability:
• Your current CV or resume;
• A covering letter (1–2 pages) outlining your motivations and relevant experience for the position. In your cover letter, please clearly state which discipline you are applying for and quote the corresponding reference number.